Remembering Phyllis Gardner, Physician and Biotechnology Innovator

A Life of Scientific Distinction

Phyllis Irene Gardner, a renowned physician-scientist and professor of medicine at Stanford Medicine, died suddenly on 2025-09-10 while vacationing on Martha’s Vineyard. She was 75 years old at the time of her passing. Dr. Gardner was widely recognized for her significant contributions to clinical pharmacology, her pioneering research into cystic fibrosis, and her unwavering commitment to scientific integrity.

Born on July 7, 1950, in Ames, Iowa, Dr. Gardner was the daughter of Franklin Gardner, an agronomist, and Opal Gardner, a homemaker. She grew up alongside her two siblings, Donald and Colleen, maintaining close familial bonds throughout her life. Her early academic journey led her to earn a Bachelor of Science degree from the University of Illinois and a medical degree from Harvard Medical School.

Career and Accomplishments

Dr. Gardner’s professional career was defined by a unique ability to bridge the gap between academic research and the biotechnology industry. After completing her internal medicine training at Massachusetts General Hospital and a chief residency at Stanford University Medical Center, she joined the Stanford faculty in 1984. She served in various leadership roles, including senior associate dean for medical education, where she influenced generations of medical students and researchers.

Beyond her academic tenure, Dr. Gardner held significant positions in the private sector, including serving as a principal scientist and vice president of research at ALZA Corporation. She was also a partner at Essex Woodlands Health Ventures, where she applied her deep expertise in drug delivery systems and corporate governance. Her work in the laboratory focused on complex biological processes, including ion channel biophysiology, cardiac arrhythmias, and the pathogenesis of cystic fibrosis.

Notable Works and Public Impact

Dr. Gardner gained broader public recognition for her role as an early skeptic of the blood-testing company Theranos. She famously advised Elizabeth Holmes that the proposed technology would likely fail, later serving as a critical source in the investigations that exposed the company’s fraudulent practices. This episode highlighted her dedication to scientific rigor and her willingness to challenge industry claims that lacked empirical support.

Her academic contributions were recognized through numerous honors, including the Burroughs Wellcome Faculty Scholar in Clinical Pharmacology award. She was also a recipient of the Judith Pool Award from the Association for Women in Science for her research achievements. Her legacy is further cemented by her extensive body of published research and her mentorship of students interested in the intersection of medicine and entrepreneurship.

Personal Life and Legacy

Dr. Gardner was deeply devoted to her family, finding strength and joy in her relationships with her husband, Andrew Perlman, and their two children, Nicola Claire Perlman and Jay Gardner Perlman. Colleagues and family members often described her as a warm, extroverted individual who brought humor and energy to her personal and professional interactions. She was a dedicated grandmother who cherished time spent with her four grandchildren.

The impact of Dr. Gardner’s work continues to be felt across the fields of medicine and biotechnology. Her career serves as a model for physicians who seek to navigate the complex boundaries between clinical practice, academic research, and commercial innovation. She is remembered by the Stanford community and her peers as a fearless advocate for truth and a transformative figure in medical education.